PNEUMOVAX II
- Licence status
- Withdrawn: 12/08/2002
- Active substances
- PNEUMOCOCCAL POLYSACCHARIDE TYPE 1 (1), PNEUMOCOCCAL POLYSACCHARIDE TYPE 2 (2), PNEUMOCOCCAL POLYSACCHARIDE TYPE 3 (3), PNEUMOCOCCAL POLYSACCHARIDE TYPE 4 (4), PNEUMOCOCCAL POLYSACCHARIDE TYPE 5 (5), PNEUMOCOCCAL POLYSACCHARIDE TYPE 8 (8), PNEUMOCOCCAL POLYSACCHARIDE TYPE 70 (33F), PNEUMOCOCCAL POLYSACCHARIDE TYPE 43 (11A), PNEUMOCOCCAL POLYSACCHARIDE TYPE 51 (7F), PNEUMOCOCCAL POLYSACCHARIDE TYPE 54 (15B), PNEUMOCOCCAL POLYSACCHARIDE TYPE 56 (18C), PNEUMOCOCCAL POLYSACCHARIDE TYPE 57 (19A), PNEUMOCOCCAL POLYSACCHARIDE TYPE 68 (9L), PNEUMOCOCCAL POLYSACCHARIDE TYPE 19 (19F), PNEUMOCOCCAL POLYSACCHARIDE TYPE 20 (20), PNEUMOCOCCAL POLYSACCHARIDE TYPE 22 (22F), PNEUMOCOCCAL POLYSACCHARIDE TYPE 23 (23F), PNEUMOCOCCAL POLYSACCHARIDE TYPE 26 (6B), PNEUMOCOCCAL POLYSACCHARIDE TYPE 34 (10A), PNEUMOCOCCAL POLYSACCHARIDE TYPE 9 (9), PNEUMOCOCCAL POLYSACCHARIDE TYPE 12 (12F), PNEUMOCOCCAL POLYSACCHARIDE TYPE 14 (14), PNEUMOCOCCAL POLYSACCHARIDE TYPE 17 (17F)
- Dosage Form
- Solution for Injection
- Licence number
- PA0544/021/001
- Licence holder
- Sanofi Pasteur MSD Ltd
Licence information
- ATC code
- Legal supply status
- Place of sale
- Marketing availability
- Advertising conditions
- Licence issued
- 15/11/1995